Clinical and Laboratory Evaluation of Acute Rejection, Myocyte Growth, Repair, and Oxidative Stress Following de Novo Cardiac Transplant: A Comparison Between Tacrolimus- and Cyclosporine - Based Immunoprophylactic Regimens With MPA TDM.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2017
At a glance
- Drugs Ciclosporin; Methylprednisolone; Mycophenolate mofetil; Mycophenolate mofetil; Prednisone; Tacrolimus
- Indications Heart transplant rejection
- Focus Biomarker; Therapeutic Use
- Sponsors Astellas Pharma; Astellas Pharma Canada
- 31 Aug 2018 Biomarkers information updated
- 12 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jul 2008 The expected completion date for this trial has changed from May 2008 to Jul 2008 as reported by ClinicalTrials.gov.